Ultragenyx Pharmaceutical, Inc. is a company in the U.S. stock market and it is a holding in 51 U.S.-traded ETFs. RARE has around 5.9M shares in the U.S. ETF market. The largest ETF holder of RARE is the iShares Russell 2000 ETF (IWM), with approximately 1.18M shares. Investors may also find of interest that the ETF with the largest allocation to RARE stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 5.75%. On average, U.S. ETFs allocate 0.49% of RARE to their portfolios.
Additionally, RARE is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with RARE as a holding is the iShares Evolved U.S. Innovative Healthcare ETF (IEIH), with a return of 3.37%.